| 000 | 01332 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514213255.0 | ||
| 264 | 0 | _c20050705 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2004.09.045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmparan, C | |
| 245 | 0 | 0 |
_aLong-term results of calcineurin-free protocols with basiliximab induction in "old-to-old" programs. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cNov 2004 |
||
| 300 |
_a2646-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aBasiliximab |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aCalcineurin |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWolters, H | |
| 700 | 1 | _aLaukötter, M | |
| 700 | 1 | _aSenninger, N | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 36 _gno. 9 _gp. 2646-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2004.09.045 _zAvailable from publisher's website |
| 999 |
_c15302080 _d15302080 |
||